Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Equity Ratio (2020 - 2026)

Rani Therapeutics Holdings' Equity Ratio history spans 7 years, with the latest figure at 0.69 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 409.0% to 0.69 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.69, a 409.0% increase, with the full-year FY2025 number at 0.71, up 642.69% from a year prior.
  • Equity Ratio came in at 0.69 for Q1 2026, down from 0.71 in the prior quarter.
  • The five-year high for Equity Ratio was 0.96 in Q1 2022, with the low at 0.78 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.35 across 5 years, with a median of 0.49 in 2023.
  • Peak annual rise in Equity Ratio hit 642.69% in 2025, while the deepest fall reached 684.47% in 2025.
  • Year by year, Equity Ratio stood at 0.69 in 2022, then plummeted by 35.87% to 0.44 in 2023, then plummeted by 78.3% to 0.1 in 2024, then surged by 642.69% to 0.71 in 2025, then decreased by 3.25% to 0.69 in 2026.
  • Business Quant data shows Equity Ratio for RANI at 0.69 in Q1 2026, 0.71 in Q4 2025, and 0.78 in Q3 2025.